Call for Abstracts

Late Breaking Abstract Submission Deadline: 10 September, 2022

EUSTM-2022 cordially invites researchers/investigators & Clinicians from various disciplines & specialties working on any aspects which have direct implications for translating into immunotherapeutics, to submit Abstracts in all areas outlined under conference themes and tracks. The conference will represent a unique multidisciplinary virtual platform to discuss latest findings, advancements and approaches covering from Biology to Patient Care. Abstracts will be selected for Oral/Poster presentations. The abstracts should be submitted via online submission form.

Congress Themes & Tracks (Immunotherapeutics (From Biology to Patient Care)


  • Advances in cellular immunology
  • Humoral & cellular Immune responses
  • B cells & T cells receptors
  • Immunomodulation
  • NK cells immunology
  • Immune tolerance
  • Experimental models
  • Immunoinformatic & systems immunology
  • Immunological surveillance & tumor immunity
  • autoimmunity
  • Cellular senescence & cancer in aging

Solid & Blood tumors

  • Cell Therapy
  • CAR-T Therapy
  • T cell receptor-based therapy
  • Tumor immunobiology
  • Novel Immunotherapies and cell therapy
  • Autoimmunity & cancer
  • Novel therapeutic targets & pathways
  • Check point inhibitors
  • Biosimilars
  • Anti-cytokines
  • Biomarkers & genetic testing in cancer immunotherapy
  • On-going clinical trials

Microbiology & Infectious Diseases

  • Infection & Novel Immunotherapeutics
  • Microbial control & therapeutics
  • Bacterial pathogenesis & Immunology
  • Antibiotics & current research
  • Viral Immunology
  • Parasite immunology
  • Novel diagnostics


  • Novel updates in Covid therapeutics
  • Covid Vaccines and potential side effects (VITT, etc)
  • Cytokine storm & Post covid syndrome


  • Vaccines & Immunotherapy
  • Novel findings & techniques
  • Vaccines induced cellular immunity
  • Vaccine & autoimmunity
  • Antibodies based therapeutics

Clinical case reports

Immunotherapeutics for Autoimmune diseases

Latest treatment guidelines & recommendations


Abstract Submission General Guidelines

  • The authors for accepted abstracts for oral talks will need to present oral talk (15/20 minutes) at the congress allocated slot time (pre-recorded) with the help of congress management team.
  • The authors for accepted abstracts for poster presentations will need to submit their E-Posters (pdf & 8/10 minutes video presentation)
  • All abstracts will be peer reviewed on rolling basis and presenting author will be notified once the committee decision is made.
  • Abstracts must be submitted via online submission system ONLY. Abstracts submitted via email, fax or by post will not be considered.
  • Please specify preferred presentation format.
  • The accepted abstracts authors will need to register for the congress to confirm their oral/poster presentation slots.
  • Multiple abstracts can be submitted for consideration by one person. But, only one talk per person would be allowed at the congress. Additional accepted abstracts for poster presentation, can be presented by another registered co-authors or by presenting author after paying additional administrative fees.
  • Please select congress track and theme that best describes your submission.
  • Abstract text must not exceed 450 words using 12-Regular Times New Roman font. In addition, up-to 3 tables and/or images can be submitted.
  • All presenters and co-authors must disclose any commercial interest/financial relationship.
  • Please proofread your abstract carefully before submission. Congress team will not be responsible for any typographical errors or other mistakes in the abstract.
  • By submitting an abstract, the presenting author confirms on behalf of all co-authors that all necessary ethical approvals and copyright permissions are obtained and confirms the originality of the work.
  • No further changes in the abstract will be permitted upon acceptance.
  • For technical help regarding abstract submission, please contact conference secretariat via email: [email protected]